The Cooper Companies, Inc. (COO)

COO Financials

COO Quarterly Income Statement (USD)

Quarterly Report	TTM	04/30/2026	01/31/2026	10/31/2025	07/31/2025	04/30/2025	01/31/2025	10/31/2024	07/31/2024
Revenue	4.231B	1.081B	1.024B	1.065B	1.060B	1.002B	964.700M	1.018B	1.003B
Cost of Goods Sold	1.507B	346.100M	328.900M	464.200M	368.300M	323.200M	304.500M	340.700M	339.800M
Gross Profit	2.724B	735.400M	695.200M	601.000M	692.000M	679.100M	660.200M	677.700M	663.000M
Gross Profit Margin	68.0%	68.0%	67.9%	56.4%	65.3%	67.8%	68.4%	66.5%	66.1%
Total Operating Expenses	2.226B	766.400M	482.400M	460.600M	516.300M	494.300M	478.200M	479.300M	470.500M
Research & Development	172.800M	42.500M	44.300M	41.400M	44.600M	45.500M	40.700M	37.700M	39.000M
Selling, General & Administrative	1.907B	676.200M	390.200M	419.200M	421.700M	399.000M	387.900M	391.400M	381.100M
Operating Income (EBIT)	497.900M	-31.000M	212.800M	140.400M	175.700M	184.800M	182.000M	198.400M	192.500M
Operating Margin	-2.9%	-2.9%	20.8%	13.2%	16.6%	18.4%	18.9%	19.5%	19.2%
Income Before Tax (EBT)	412.500M	-48.400M	192.200M	116.800M	151.900M	144.500M	153.300M	168.600M	163.700M
Interest Income	—	—	—	—	—	—	—	—	—
Interest Expense	93.100M	20.900M	22.400M	24.400M	25.400M	33.300M	26.000M	27.000M	28.500M
Other Income/Expense	-85.400M	-17.400M	-20.600M	-23.600M	-23.800M	-40.300M	-28.700M	-29.800M	-28.800M
Net Income	235.800M	-77.900M	130.800M	84.600M	98.300M	87.700M	104.300M	117.500M	104.700M
Income Tax Expense	176.700M	29.500M	61.400M	32.200M	53.600M	56.800M	49.000M	51.100M	59.000M
Net Profit Margin	-7.2%	-7.2%	12.8%	7.9%	9.3%	8.7%	10.8%	11.5%	10.4%
EBITDA	865.900M	67.900M	310.100M	215.200M	272.700M	261.300M	270.300M	286.600M	281.200M
EBITDA Margin	6.3%	6.3%	30.3%	20.2%	25.7%	26.1%	28.0%	28.1%	28.0%
Depreciation & Amortization	384.700M	95.400M	95.500M	98.400M	95.400M	92.600M	91.000M	91.000M	89.000M
EPS Basic	1.18	-0.40	0.66	0.43	0.49	0.44	0.52	0.59	0.53
EPS Diluted	1.18	-0.40	0.66	0.43	0.49	0.44	0.52	0.58	0.52
Shares Outstanding	195.000M	195.000M	196.700M	198.100M	200.600M	199.900M	201.200M	201.100M	199.100M
Diluted Shares Outstanding	195.000M	195.000M	196.700M	198.100M	200.600M	200.700M	201.200M	201.100M	200.600M

COO Annual Income Statement (USD)

Annual Report	10/31/2025	10/31/2024	10/31/2023	10/31/2022	10/31/2021	10/31/2020	10/31/2019	10/31/2018
Revenue	4.092B	3.895B	3.593B	3.308B	2.922B	2.431B	2.653B	2.533B
Cost of Goods Sold	1.609B	1.300B	1.235B	1.169B	966.700M	896.100M	896.600M	900.500M
Gross Profit	2.483B	2.596B	2.358B	2.140B	1.956B	1.535B	1.757B	1.632B
Gross Profit Margin	60.7%	66.6%	65.6%	64.7%	66.9%	63.1%	66.2%	64.4%
Total Operating Expenses	1.800B	1.890B	1.825B	1.632B	1.450B	1.223B	1.229B	1.205B
Research & Development	172.200M	155.100M	137.400M	110.300M	92.700M	93.300M	86.700M	84.800M
Selling, General & Administrative	1.628B	1.534B	1.501B	1.342B	1.211B	992.500M	996.600M	973.300M
Operating Income (EBIT)	682.900M	705.700M	533.100M	507.600M	505.800M	311.800M	546.700M	403.100M
Operating Margin	16.7%	18.1%	14.8%	15.3%	17.3%	12.8%	20.6%	15.9%
Income Before Tax (EBT)	566.500M	582.300M	412.900M	475.300M	491.500M	266.500M	477.400M	331.900M
Interest Income	—	—	—	—	—	—	—	—
Interest Expense	100.000M	114.300M	105.300M	57.300M	23.100M	36.800M	68.000M	82.700M
Other Income/Expense	-116.400M	-123.400M	-120.200M	-32.300M	-14.300M	-45.300M	-91.400M	-71.200M
Net Income	374.900M	392.300M	294.200M	385.800M	2.945B	238.400M	466.700M	139.900M
Income Tax Expense	191.600M	190.000M	118.700M	89.500M	-2.453B	28.100M	10.700M	192.000M
Net Profit Margin	9.2%	10.1%	8.2%	11.7%	100.8%	9.8%	17.6%	5.5%
EBITDA	1.053B	1.072B	885.900M	878.700M	823.900M	590.400M	826.200M	689.700M
EBITDA Margin	25.7%	27.5%	24.7%	26.6%	28.2%	24.3%	31.1%	27.2%
Depreciation & Amortization	423.000M	375.100M	367.700M	346.100M	309.300M	287.100M	280.800M	275.100M
EPS Basic	1.88	1.97	1.49	1.96	59.73	4.86	9.47	2.85
EPS Diluted	1.87	1.96	1.48	1.94	59.07	4.81	9.32	2.81
Shares Outstanding	200.000M	198.900M	198.000M	197.200M	197.200M	196.400M	197.200M	196.400M
Diluted Shares Outstanding	200.000M	200.400M	199.200M	198.800M	199.400M	198.200M	200.200M	198.800M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About The Cooper Companies, Inc.

The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.

San Ramon, CA

16,000 employees

www.coopercos.com

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: Albert G. White

View full financials